Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
Recruiting
Observational Study
Septic Patients Admitted to the ICU
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 155 (estimated)
- Sponsor
- Meir Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Sepsis is one of the most common causes of ICU admission. About 5-15% of patients admitted to the hospital with an infection will have sepsis, and about 30-40% of them will have septic shock. About 34% of septic patients and about 53% of patients with septic shock will die within 28 days of admission. Broad-spectrum empiric antibiotic treatment (depending on the source of infection and patient ris…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients admitted to the general ICU due to sepsis or septic shock between 1/1/20 and 31/12/20
Exclusion Criteria: Patients who were admitted due to other non-infectious etiologies
\-
Contacts
No contact information available.